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M A J O R A R T I C L E
Chickenpox and Risk of Stroke: A Self-controlled
Case Series Analysis
Sara L. Thomas,1 Caroline Minassian,1 Vijeya Ganesan,2 Sinéad M. Langan,1 and Liam Smeeth1
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine; and 2Institute of Child Health, University College
London, United Kingdom
Background. There is good evidence that respiratory and other infections that cause systemic inﬂammation can
trigger strokes; however, the role of speciﬁc infections is unclear. Case reports have highlighted chickenpox as a pos-
sible risk factor for arterial ischemic stroke, particularly in children, but rigorous studies are needed to determine
and quantify any increased risk.
Methods. We used anonymized electronic health records totaling >100 million person-years of observation
from 4 UK primary care databases to identify individuals who had documented clinical chickenpox and a stroke or
transient ischemic attack (TIA). Self-controlled case series methods were used to quantify any increased risk of ﬁrst
stroke or TIA in the 0–6 and 7–12 months following chickenpox compared to other observed time periods. We ana-
lyzed data within each database, and performed meta-analyses to obtain summary age-adjusted incidence ratios
(IRs) separately for adults and children.
Results. Five hundred sixty eligible individuals (including 60 children) were identiﬁed who experienced chick-
enpox and a stroke or TIA during follow-up. Among children, there was a 4-fold increased risk of stroke in the 0–6
months after chickenpox (summary IR = 4.07; 95% conﬁdence interval [CI], 1.96–8.45; I2 = 0%). Among adults,
there was a less marked increased risk with moderate between-database heterogeneity (random-effects summary
IR = 2.13; 95% CI, 1.05–4.36; I2 = 51%). There was no signiﬁcant increased risk of stroke in the 7–12 months after
chickenpox in children or adults, nor was there evidence of increased risk of TIA in either time period.
Conclusions. Our study provides new evidence that children who experience chickenpox are at increased risk of
stroke in the subsequent 6 months.
Keywords. chickenpox; stroke; child; adult; risk factors.
There is increasing epidemiological evidence that acute
infections can trigger arterial ischemic stroke (AIS) [1].
For example, we have shown that acute systemic respi-
ratory and urinary tract infections were each associated
with an increased stroke risk in the 3 months after
infection [2]. Suggested mechanisms include athero-
sclerotic plaque rupture and embolism, increased
local coagulability, and impairment of endothelial func-
tion [1, 3, 4]. Unlike adult strokes, childhood AISs are
nonatheromatous; the relationship between infection
and pediatric AIS has been less investigated, but a recent
US case-control study reported that a medical consulta-
tion for minor acute infection was associated with a 4.6-
fold increased risk of childhood AIS in the subsequent
month [5]. Antecedent infection is also signiﬁcantly as-
sociated with focal intracranial arteriopathy, a common
ﬁnding in childhood AIS [6]. Thus, as well as the mecha-
nisms postulated in adults, these data suggest that infec-
tion may induce focal intracranial arteriopathy, probably
inﬂammatory, in some children with AIS.
Although broad categories of infections have been
shown to be associated with increased stroke risk, few
studies have investigated the role of speciﬁc pathogens.
One infectious agent identiﬁed as a possible trigger for
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AIS is varicella zoster virus (VZV), which can replicate in cere-
bral arterial walls and thus is a plausible cause of cerebral arte-
riopathy [7]. Cases of childhood AIS or transient ischemic
attack (TIA) occurring in the months after chickenpox
(primary VZV infection) have been thought to represent a vas-
culitis, resulting either from direct viral invasion or as a postin-
fectious phenomenon [8–10]. Cases of AIS following
chickenpox have also been reported in adults, and the purport-
ed effect may not be restricted to children [11–14].
Because chickenpox is common among children, individual
case reports of chickenpox prior to stroke could be explained
by chance and do not provide clear evidence of increased risk.
Rigorous epidemiological studies are thus needed to quantify
any increased risk of AIS following chickenpox. The challenge
is that children and adults with and without chickenpox differ
in ways that are difﬁcult to capture and control for. In addition,
very large prospective data are needed. We therefore used UK
electronic health records and the self-controlled case series
method to eliminate between-person confounding and test the
hypothesis that children and adults who develop chickenpox
are at increased risk of AIS in the subsequent 12 months.
METHODS
Data Sources
We combined data from 4 large UK general practice databases of
anonymized electronic health records, totaling >100 million
person-years of observation: (1) the General Practice Research
Database (GPRD), one of the world’s largest and best-established
research databases of electronic primary care data; (2) QResearch,
which holds data for >12 million patients; (3) The Health Im-
provement Network (THIN), with >9 million patients; and (4)
IMS Disease Analyzer Mediplus, with >2 million patients. These
databases include information on patients’ consultations, diagnos-
es, prescriptions, and outcomes of hospitalizations/specialist refer-
rals, and all have been widely used for epidemiological research.
Study Design
The within-person self-controlled case series method utilizes
data only from cases (individuals with stroke) and allows estima-
tion of the relative incidence of a stroke in deﬁned intervals fol-
lowing acute exposures (chickenpox) compared to other periods
in the same individuals [15]. This study design provided 3 major
advantages for our study question. First, as comparisons are
made entirely within individuals, between-person confounding
was addressed. Second, not all individuals with chickenpox
attend their general practitioner, but because the method uses
only exposed cases (individuals who experienced both chicken-
pox and stroke), underascertainment of chickenpox was avoided.
Third, stroke in childhood is uncommon, but the design is statis-
tically efﬁcient and thus increases study power [15].
Study Period
Individuals’ follow-up started at the later of the date they regis-
tered with the practice and either the date from which the data
met database-deﬁned quality standards (GPRD and QRe-
search), practice computerization date (THIN), or 1 January
1990 (IMS Health: a conservative estimate of practice comput-
erization date). Because diagnoses recorded in the ﬁrst year of
follow-up in primary care databases can be past events recorded
retrospectively, each individual’s study period started 1 year
after the start of their follow-up and ended at the earliest of the
date they died, left the practice, or the practice’s last data collec-
tion date (up to January 2011, depending on the database) [16].
Thus, individuals were at least 1 year of age at the study start.
Exposure and Outcome
Medical records with chickenpox, stroke, and TIA diagnoses
were identiﬁed using Read code lists (Supplementary Tables 1
and 2). To distinguish strokes from TIAs, we combined all
stroke and TIA records into episodes; records occurring within
28 days of one another were considered to be part of an
ongoing episode. The episode was then categorized as either a
TIA or a stroke using the Read codes within that episode; a TIA
episode comprised only TIA records. Episodes with codes indi-
cating a hemorrhagic or venous stroke were also identiﬁed for
later exclusion. We restricted analyses to the ﬁrst stroke episode
in the study period (the index stroke) to avoid the possibility that
a subsequent stroke “episode”was an ongoing (not a new) stroke
and to fulﬁll the assumption of self-controlled case series methods
that events should be independent within a person [15].
Eligibility Criteria
Potentially eligible individuals were those who had a ﬁrst-ever
clinical diagnosis of both chickenpox and stroke (or TIA)
during their study period. We excluded individuals who had
documented chickenpox or stroke/TIA before the study period,
or on the same day as a “new-patient” or “well-patient” health
check, which could be a recording of a past event. To restrict
the outcome to AIS, we excluded individuals whose ﬁrst stroke
episode was classiﬁed as a hemorrhagic or venous stroke, and
individuals whose ﬁrst stroke was documented entirely with
nonspeciﬁc diagnostic codes (eg, “cerebrovascular accident”)
but who also had a risk factor for hemorrhagic stroke anywhere
in their medical data—for example, a cerebral arteriovenous
malformation or a nontraumatic subarachnoid hemorrhage (as
a proxy for an arteriovenous malformation/aneurysm). Finally,
meningitis and encephalitis are rare complications of chicken-
pox, and their initial presentation can mimic that of a stroke.
We therefore excluded any individual who had a varicella-
speciﬁc or nonspeciﬁcmeningitis or encephalitis diagnostic code
in the year after their stroke diagnosis.
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General practices that contribute data to QResearch or to
IMS are mutually exclusive and do not contribute to the other
databases. Some practices contribute data to both GPRD and to
THIN and so potentially some patients with chickenpox and
stroke could have been duplicated in the GPRD and THIN da-
tasets. We identiﬁed GPRD/THIN duplicated cases on the basis
of year of birth, sex, geographical region of the practice, and
dates of chickenpox and stroke, and excluded these cases from
the THIN dataset.
Analysis
Self-controlled case series analyses were ﬁrst carried out sepa-
rately for each of the 4 datasets. The “exposed” period for each
individual started the day after their ﬁrst chickenpox consulta-
tion and extended up to a year, consistent with previous case
reports; we subdivided this exposed period into 0–6 months
and 7–12 months after chickenpox. All remaining time in an
individual’s study period was considered “unexposed” baseline
(Figure 1). We used conditional Poisson regression to calculate
incidence ratios (IRs) for the ﬁrst-ever stroke or TIA occurring
in each of the 2 exposed periods compared to baseline, adjust-
ing for age in 5-year age bands. Age-adjusted analyses were
stratiﬁed into 2 age groups: Those who experienced both chick-
enpox and stroke/TIA before 18 years of age contributed to the
“child” stratum (with censoring at 18 years), and those experi-
encing both these events at ≥18 years were included in the
“adult” stratum (starting follow-up at 18 years). We examined
the effect of chickenpox on any cerebrovascular event (stroke
or TIA), and separately on strokes and TIAs.
We investigated heterogeneity between the database-speciﬁc
IRs using the Cochrane Q statistic and I2 statistic [17]. When
there was no evidence of heterogeneity, we combined the data
using ﬁxed-effect meta-analysis to obtain a summary IR; we
also combined the data into a single dataset and repeated case
series analyses, comparing the IR obtained from the combined
dataset with that from the meta-analysis. When evidence of
heterogeneity was found, a random-effects meta-analysis was
used to obtain a summary IR and the data were not further
combined.
Two key assumptions of the self-controlled case series
method are that the observation period for each individual is
independent of the timing of their clinical event, and that the
occurrence of the clinical event does not affect the likelihood of
subsequent exposure to the risk factor [15]. These assumptions
may not hold for an event such as stroke that increases the mor-
tality rate, because subsequent exposure to chickenpox is im-
possible after death and the observation period is censored at
death and so is event-dependent. To assess whether this had af-
fected our study results, we carried out a sensitivity analysis
after excluding individuals whose study period ended within a
month of their stroke (possibly indicating death).
All analyses were carried out using Stata software, release 12
(StataCorp, College Station, Texas).
Ethics Approval
The study received approval from the scientiﬁc/ethics advisory
group of the 4 databases, and from the ethics committee of the
London School of Hygiene and Tropical Medicine.
RESULTS
We identiﬁed from the 4 databases 645 potentially eligible cases
with a ﬁrst-ever recorded stroke or TIA and a ﬁrst chickenpox
consultation during their study period. Of these, 77 were
Figure 1. Pictorial representation of self-controlled case-series study design, showing the risk periods and baseline periods for a single patient whose
ﬁrst stroke could occur at any time during the study period.
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excluded: 26 had their ﬁrst stroke and/or ﬁrst chickenpox
record on the same day as a new- or well-person check-up, 50
had a hemorrhagic or venous ﬁrst stroke, 1 had evidence of a
subarachnoid hemorrhage, and 1 had a varicella meningitis
record 24 days after their ﬁrst stroke. Eight further individuals
were excluded because they had chickenpox outside their age-
determined observation period (had stroke or TIA as an adult
but chickenpox as a child, or vice versa).
Characteristics of the 560 remaining eligible individuals are
given in Table 1. Sixty individuals had their ﬁrst chickenpox
and ﬁrst stroke/TIA diagnosis in childhood (median age, 3.9
years; interquartile range [IQR], 1.9–6.4 years), and 500 had
both chickenpox and ﬁrst stroke/TIA as an adult (median age,
62.9 years; IQR, 49.2–75.4 years). Just over half the sample in
each age category was male. Almost all ﬁrst episodes in children
were strokes, whereas just over half of the adult ﬁrst episodes
were TIAs (Table 1).
Results of database-speciﬁc analyses and summary effect es-
timates are given in Figures 2 and 3 (and Supplementary
Table 3). Fourteen children experienced a stroke or TIA in the
6 months after chickenpox compared to 39 during baseline
periods; an elevated risk was found in all 4 datasets, with no ev-
idence of between-database heterogeneity (Pheterogeneity = .88;
I2 = 0%) The summary effect estimate (using a ﬁxed-effect
model) indicated that children were at a >3-fold increased risk
of stroke or TIA in the 6 months following chickenpox
(summary IR = 3.58; 95% conﬁdence interval [CI], 1.84–6.95;
Figure 2A). There was also an indication of elevated stroke/TIA
risk 7–12 months after chickenpox, with 7 children experienc-
ing a stroke during this period, although the ﬁxed-effect
summary incidence ratio did not reach statistical signiﬁcance
(Figure 2A). After combining the data from the 4 datasets and
repeating analyses, very similar estimates were obtained (Sup-
plementary Table 3).
In contrast, among adults the incidence ratios for a stroke or
TIA in the year after chickenpox were less marked (Figure 2B)
and varied between datasets (0–6 months: I2 = 61%; 7–12
months: I2 = 55%). The results of random-effects meta-analyses
provided nonsigniﬁcant 44% and 30% increased risks for the 2
post–chickenpox risk periods, with 29 and 23 adults experienc-
ing a stroke 0–6 and 7–12 months after chickenpox, respective-
ly, compared to 448 during baseline.
Effects of chickenpox were more pronounced after restricting
analyses to individuals whose ﬁrst cerebrovascular event was a
stroke (Figure 3). Among the 49 children with a stroke, the
summary IR in the 0–6 months after chickenpox rose to 4.07
(95% CI, 1.96–8.45; I2 = 0%), and among the 241 adults the
(random-effects) summary IR also rose and reached statistical
signiﬁcance, although moderate between-database heterogenei-
ty remained (IR = 2.13; 95% CI, 1.05–4.36; I2 = 51%). The
summary IRs for strokes in the 7–12 months after chickenpox
were not appreciably different from the estimates for strokes/
TIAs (Figure 3). Analyses restricted to TIAs were not per-
formed for children as so few had a documented TIA; results
from the combined adult data showed little evidence of an asso-
ciation between chickenpox and TIA (0–6 months: IR = 0.85;
95% CI, .43–1.68; Supplementary Table 4).
Repeating analyses after excluding the 1 child and 15 adults
whose study period ended <1 month after stroke diagnosis had
little effect on the magnitude of effect estimates. The incidence
ratio for stroke among children in the 6 months after chicken-
pox rose very slightly (ﬁxed-effect summary IR = 4.16; 95% CI,
2.00–8.69) and was very similar to the main estimate for the
subsequent 6 months (Supplementary Figure 1A). Among
adults, between-database heterogeneity remained, and random-
effects summary estimates were similar to the main ﬁndings
(Supplementary Figure 1B).
DISCUSSION
Our study shows that among children, chickenpox is associated
with an increased risk of stroke in the subsequent 6 months.
This supports the assertion that chickenpox is a risk factor for
stroke, which until now has been based largely on case reports.
We found a less marked nonsigniﬁcant increased risk of stroke
7–12 months after chickenpox, further suggesting a reactive
process that resolves over time. Among adults, there was less
convincing evidence of an increased risk of stroke following
chickenpox.
To our knowledge, this is the ﬁrst robust evidence that chick-
enpox increases the risk of stroke. One previous case-control
study of 11 children with AIS found that 7 (64%) had experi-
enced chickenpox in the previous 9 months compared with 9%
of 44 controls, giving a crude odds ratio of 17.5 (95% CI, 2.8–
126.1) [18]. The ﬁndings were limited by the small sample size
and no adjustment for confounding. A second study of 70
childhood AIS cases, with no formal comparison group, report-
ed that 31% had chickenpox in the previous year, 3 times the
estimated national population rate [19]. In our study, within-
person comparisons meant that confounding was largely ad-
dressed. Confounding could have occurred only if individuals
had risk factors for stroke that changed over time, if these
factors were also associated with the timing of chickenpox, and
if these time-dependent effects existed for a high proportion of
study participants. Our use of exposed cases, whose chickenpox
was diagnosed by a general practitioner, meant that the study
did not depend on patient recall and minimized misclassiﬁca-
tion of chickenpox status. We provide a more precise estimate
of increased risk due to our larger number of stroke cases and
statistically powerful design. Also, our ﬁndings should be
highly generalizable, as almost the entire UK population is reg-
istered with a general practice.
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Very few children presented with a TIA. The differential di-
agnosis of childhood transient focal neurological deﬁcits is
wide, reducing conﬁdence in these events having a deﬁnite vas-
cular basis. Diagnosis of TIA may also be imprecise in adults,
which could partly explain the lack of a demonstrable association
between chickenpox and adult TIA. A further possible explana-
tion relates to the underlying assumption of self-controlled case
series methods that clinical events are independent within indi-
viduals. As this may not be true for strokes/TIAs, because having
1 stroke/TIA increases the likelihood of another one, we restrict-
ed analyses to individuals’ ﬁrst stroke/TIA. This is a reasonable
strategy when the event is relatively uncommon during the
observation period and has been widely used in previous self-
controlled case series stroke studies [2, 15, 20–22]. However,
inclusion of TIAs as an additional outcome could have made
cerebrovascular events less uncommon, particularly among
adults.
Even after restricting analyses among adults to those whose
ﬁrst event was a stroke, there was unexplained between-data-
base heterogeneity in effect estimates. The summary estimate
for adults thus needs to be treated with caution, and merits
further study. The observed differences in the effect of chicken-
pox in adults and children may be partly due to mechanistic
differences, as childhood AIS is nonatheromatous and focal
vasculopathy, probably inﬂammatory in origin, is likely to play
a greater role.
Limitations of our study need consideration. Self-controlled
case series analyses only produce estimates of relative incidence,
so we could not quantify the absolute risk of stroke following
chickenpox. Despite combining data from 4 large general prac-
tice databases, our overall sample size was modest, preventing
ﬁner stratiﬁcation of the initial risk period to see if there was a
greater elevation of risk within the ﬁrst few weeks follow-
ing chickenpox, as has been shown for other infections and
stroke [2]. Chickenpox has a highly characteristic clinical pre-
sentation and is readily diagnosed by general practitioners. Any
misdiagnosis is thus likely to have been at a low level, producing
only a small bias toward no effect. Many of the stroke episodes
we identiﬁed were categorized as “nonspeciﬁc,” and some
could have been unrecognized hemorrhagic strokes. VZV infec-
tion could also increase the risk of cerebral aneurysm and hem-
orrhage, but this is probably uncommon and inclusion of
hemorrhagic strokes may therefore have lessened the associa-
tion with recent chickenpox [7]. Previous large validation
studies in GPRD and THIN have demonstrated high validity of
a stroke diagnosis in these data [23, 24]. A small number of
events labeled as stroke could potentially have been varicella
meningitis or encephalitis. However, we think this is unlikely in
children, among whom stroke is an uncommon diagnosis that
is not made readily. We did exclude the 1 case who had a vari-
cella meningitis code after a stroke, although this meningitisTa
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could have been secondary to cerebral arteriopathy [7]. Our
sensitivity analyses also suggested that premature death was un-
likely to have affected our study ﬁndings. Given our inclusion
criteria, our results may not apply to those who have experi-
enced a previous stroke, or to risk of hemorrhagic stroke.
In conclusion, our study provides new evidence that children
who experience chickenpox are at increased risk of AIS over the
subsequent months and that stroke is a rare complication of
childhood chickenpox. The 4-fold increased risk we identiﬁed
will represent only a small absolute stroke risk, given the low
Figure 2. Age-adjusted incidence ratios (IRs) for stroke or transient ischemic attack in periods following chickenpox, in children and adults. For each da-
tabase, the central diamond and line correspond to the IR and 95% conﬁdence interval, and the area of the gray square reﬂects the weight of the study.
Abbreviations: CI, conﬁdence interval; GPRD, General Practice Research Database; IR, incidence ratio; THIN, The Health Improvement Network.
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baseline incidence of pediatric stroke. Nevertheless, AIS is
increasingly recognized among children and is associated
with considerable morbidity and mortality, with up to three-
quarters of survivors experiencing neurological and/or cognitive
sequelae [25, 26]. Our ﬁndings suggest that the renewed atten-
tion on the mechanisms by which VZV and other infections
cause vascular injury is warranted and could identify strategies
to prevent strokes [27].
Figure 3. Age-adjusted incidence ratios (IRs) for stroke in periods following chickenpox, in children and adults. For each database, the central diamond
and line correspond to the IR and 95% conﬁdence interval, and the area of the gray square reﬂects the weight of the study. Abbreviations: CI, conﬁdence
interval; GPRD, General Practice Research Database; IR, incidence ratio; THIN, The Health Improvement Network.
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Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online
(http://cid.oxfordjournals.org/). Supplementary materials consist of data
provided by the author that are published to beneﬁt the reader. The posted
materials are not copyedited. The contents of all supplementary data are the
sole responsibility of the authors. Questions or messages regarding errors
should be addressed to the author.
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